The Mayo Clinic experience with the use of kinase inhibitors, ipilimumab, bevacizumab, and local therapies in the treatment of metastatic uveal melanoma-Reference-Cited by-同舟云学术

The Mayo Clinic experience with the use of kinase inhibitors, ipilimumab, bevacizumab, and local therapies in the treatment of metastatic uveal melanoma

Published:2015-02 Issue:1 Volume:25 Page:59-63
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Moser Justin C.,Pulido Jose S.,Dronca Roxana S.,McWilliams Robert R.,Markovic Svetomir N.,Mansfield Aaron S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference14 articles.

1. Very long-term prognosis of patients with malignant uveal melanoma.;Kujala;Invest Ophthalmol Vis Sci,2003

2. Metastatic uveal melanoma therapy: current options.;Bedikian;Int Ophthalmol Clin,2006

3. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma.;Kim;Arch Ophthalmol,2010

4. . Metastatic uveal melanoma: is there a role for conventional chemotherapy A single center study based on 58 patients.;Pons;Melanoma Res,2011

5. A pilot study of sunitinib malate in patients with metastatic uveal melanoma.;Mahipal;Melanoma Res,2012

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis;Scientific Reports;2024-04-03

2. Chemoembolization Beyond Hepatocellular Carcinoma: What Tumors Can We Treat and When?;Seminars in Interventional Radiology;2024-02

3. Inhibition of CD146 lessens uveal melanoma progression through reducing angiogenesis and vasculogenic mimicry;Cellular Oncology;2022-06-18

4. Novel Prognostic Immunohistochemical Markers in Uveal Melanoma-Literature Review;Cancers;2021-08-10

5. Development of new therapeutic options for the treatment of uveal melanoma;The FEBS Journal;2021-05